STERIS Irish FinCo Unlimited Company, founded in 2019 and headquartered in Ireland, serves as a financial subsidiary of STERIS plc focused on providing innovative healthcare solutions. The company specializes in manufacturing and distributing a range of sterilization and infection prevention products widely utilized in the medical and laboratory sectors.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| STE 2.70% 2031-03-15 USDSTERIS Irish FinCo Unlimited Company | Ireland | 2031-03-15 | 2.700 | 4.45 |
| STE 3.75% 2051-03-15 USDSTERIS Irish FinCo Unlimited Company | Ireland | 2051-03-15 | 3.750 | 5.95 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, STERIS Irish FinCo has actively engaged in the bond market, issuing its first bonds in 2020 to support expansion initiatives. Notably, a significant issuance in 2022 raised €500 million with a 2.5% yield, offering a competitive rate compared to the industry average. This issuance was instrumental in financing strategic acquisitions aimed at enhancing their product portfolio. Currently, the company maintains a strong presence in the bond market, reflecting positive investor sentiment and strategic financial management.